These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10602447)

  • 21. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein H promoter polymorphisms in relation to lupus and lupus-related phenotypes.
    Suresh S; Demirci FY; Jacobs E; Kao AH; Rhew EY; Sanghera DK; Selzer F; Sutton-Tyrrell K; McPherson D; Bontempo FA; Kammerer CM; Ramsey-Goldman R; Manzi S; Kamboh MI
    J Rheumatol; 2009 Feb; 36(2):315-22. PubMed ID: 19132787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphospholipid antibodies.
    Sanghera DK; Manzi S; Bontempo F; Nestlerode C; Kamboh MI
    Hum Genet; 2004 Oct; 115(5):393-8. PubMed ID: 15322919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism.
    Sanghera DK; Kristensen T; Hamman RF; Kamboh MI
    Hum Genet; 1997 Jul; 100(1):57-62. PubMed ID: 9225969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein H genetic variability in the population of Krk Island, Croatia.
    Vitale K; Trbojević-Cepe M; Smolej-Narancić N
    Hum Biol; 2002 Aug; 74(4):545-54. PubMed ID: 12371681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.
    Dinu AR; Merrill JT; Shen C; Antonov IV; Myones BL; Lahita RG
    Lupus; 1998; 7(5):355-60. PubMed ID: 9696140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement.
    Amoroso A; Cacciapaglia F; De Castro S; Battagliese A; Coppolino G; Galluzzo S; Vadacca M; Afeltra A
    Clin Exp Rheumatol; 2006; 24(3):287-94. PubMed ID: 16870096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
    Svenungsson E; Gustafsson J; Leonard D; Sandling J; Gunnarsson I; Nordmark G; Jönsen A; Bengtsson AA; Sturfelt G; Rantapää-Dahlqvist S; Elvin K; Sundin U; Garnier S; Simard JF; Sigurdsson S; Padyukov L; Syvänen AC; Rönnblom L
    Ann Rheum Dis; 2010 May; 69(5):834-40. PubMed ID: 19762360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid syndrome: 30 years and our contribution.
    Koike T
    Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study.
    Fijnheer R; Roest M; Haas FJ; De Groot PG; Derksen RH
    J Rheumatol; 1998 Sep; 25(9):1737-42. PubMed ID: 9733454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus.
    Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
    Lupus; 1995 Dec; 4(6):472-6. PubMed ID: 8749570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.